Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | FABP5 | Q01469 | 3/20 | 0.44 |
| ▸ | FABP7 | O15540 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL27739367 | 0.94 | KMT2A (0.48) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL15160787 | 0.90 | KMT2A (0.47) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL29647898 | 0.87 | KMT2A (0.46) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL13068845 | 0.87 | KMT2A (0.46) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL12665926 | 0.87 | KMT2A (0.46) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL29776411 | 0.86 | KMT2A (0.45) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL7853751 | 0.85 | KMT2A (0.55) | KMT2AFABP5FABP7EPHX2CASP3 | |
| SCHEMBL14656652 | 0.85 | KMT2A (0.47) | KMT2AFABP5FABP7CA1CA2 | |
| SCHEMBL29989813 | 0.85 | KMT2A (0.55) | KMT2AFABP5FABP7EPHX2CASP3 | |
| SCHEMBL13359306 | 0.84 | BCHE (0.48) | KMT2AFABP5FABP7CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1984726-B1 | METHODS, MIXTURES, KITS AND COMPOSITIONS PERTAINING TO ANALYTE DETERMINATION | DH TECHNOLOGIES DEV PTE LTD (SG) | 2015-06-17 | — | — | EP | disclosed |
| US-8975404-B2 | Labeling reagents for analyte determination and methods and compounds used in making the same | DH TECHNOLOGIES DEVELOPMENT PTE. LTD. (SG) | 2015-03-10 | — | — | US | disclosed |
| US-20120142718-A1 | N-17-Alkylated Prodrugs of Opioids | SIGNATURE THERAPEUTICS, INC. | 2012-06-07 | — | — | US | disclosed |
| US-20120142718-A1 | N-17-Alkylated Prodrugs of Opioids | SIGNATURE THERAPEUTICS, INC. | 2012-06-07 | — | — | US | disclosed |
| CN-101421609-A | The method relevant, potpourri, kit and composition with analyte determination | APPLERA CORP (US) | 2009-04-29 | — | — | CN | disclosed |
| EP-1984726-A2 | METHODS, MIXTURES, KITS AND COMPOSITIONS PERTAINING TO ANALYTE DETERMINATION | Applera Corporation (US) | 2008-10-29 | — | — | EP | disclosed |
| US-20070218560-A1 | Methods, Mixtures, Kits and Compositions Pertaining to Analyte Determination | APPLERA CORPORATION. (US) | 2007-09-20 | — | — | US | disclosed |
| WO-2007087534-A2 | METHODS, MIXTURES, KITS AND COMPOSITIONS PERTAINING TO ANALYTE DETERMINATION | APPLERA CORPORATION (US) | 2007-08-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142718-A1 | N-17-Alkylated Prodrugs of Opioids | OPRM1, OPRD1, OPRL1 | KMT2A 827/4885FABP5 3922/4885FABP7 1868/4885 |
| US-20070218560-A1 | Methods, Mixtures, Kits and Compositions Pertaining to Analyte Determination | SRMS, CA13, KLK3 | KMT2A 2584/4885FABP5 441/4885FABP7 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.